GSK, MedImmune License Pact Draws Notice To Staph Wars
By Randall Osborne
Monday, September 5, 2005
The anti-staph field got potentially more complicated last week when a would-be challenge to research leader Inhibitex Inc. appeared on the horizon.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.